The critical role of Orai3 in cell survival of breast cancer cells came also clear upon siRNA delivery via nanoparticles, which decreased the viability of breast cancer cells (T47D) [174], but not of healthy cell types (MCF10A). Here, ORAI3 is linked to breast cancer.